Global Biopharmaceutical Logistics Market: Overview
Logistics is an essential segment of supply chain management. Logistics allows the pharmaceutical companies to establish consistency as well as efficiency through the international supply chain market. The pharmaceutical sector opts logistics for a complete management of acquiring, storing and moving the resources to the end users as per their needs. Logistics provides a continuous supply of bio pharmaceutical products like vaccines, anti-bodies, somatic cells and other biomolecules from sellers and traders in different places. It also allows the transport of pharmaceutical drugs which do not require cold chain control. Nowadays, the pharmaceutical companies have even started to outsource the logistics domain of the company to the third parties. Logistics market is gaining popularity due to fast track execution and better communication, even this market is in constant process to reduce packaging costs. The market has also witnessed rapid growth due to mergers and acquisitions by the existing players. The market for biopharmaceutical logistics shall be driven by factors such as logistics providers having local contacts and know-how, innovation in packaging and increased manufacture and use of biologic drugs.
This 122 page report gives readers a comprehensive overview of the Biopharmaceutical Logistics market Browse through 72 data tables and 49 figures to unlock the hidden opportunities in this market.
Global Biopharmaceutical Logistics Market: Scope of the Report
This report on the global biopharmaceutical logistics market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Bn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market volume data (tonnage) for the period 2014 to 2024 has been provided for the mode of transportation segment at regional and country level.
Market related factors such as technological developments, service innovations, expansion of infrastructural facilities such as warehousing networks by major players and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the global biopharmaceutical logistics market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Global Biopharmaceutical Logistics Market: Segmentation
Based on type, the global biopharmaceutical logistics market has been segmented into cold chain logistics and non-cold chain logistics. Although the overall pharmaceutical market has more products requiring non-cold chain based logistics transport, the market for cold chain is witnessing a higher growth rate owing to the rise in manufacture and transport of biologic drugs and those drugs which require temperature controlled shipping.
The principal modes of transportation for biopharmaceutical logistics include air shipping, sea shipping, road shipping and rail shipping. New regulations in the U.S., the European Union, and elsewhere, has radically lengthened the list of drugs requiring temperature-controlled handling. Specifically, new rules for handling products that fall into the controlled ambient (15 to 25 degrees C) category has upsurged the demand for temperature controlled handling. This has led to many pharmaceutical companies resorting to air shipping for such critical products. However, concerns over cost containment has led to the trend of increased preference for transporting pharmaceuticals by sea and road, wherever possible.
Geographically, the global Biopharmaceutical Logistics market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been further segmented by major countries. Considerable growth in biopharma logistics is expected in the emerging countries in Asia compared to North America and Europe.
Companies Mentioned in the Report
The report also profiles major players in the Biopharmaceutical Logistics market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include FedEx Corporation, Ceva Logistics LLC, Amerisource Bergen Corporation, Panalpina Group, Kuehne + Nagel International AG, XPO Logistics, Inc., United Parcel Service, Inc., Deutsche Post DHL Group, DB Schenker and C.H. Robinson Worldwide, Inc.
Get accurate market forecast and analysis on the Biopharmaceutical Logistics market. Request a sample to stay abreast on the key trends impacting this market.
The global biopharmaceutical logistics market has been segmented as follows:
Global Biopharmaceutical Logistics Market, by Type
Cold Chain Logistics
Non-cold Chain Logistics
Global Biopharmaceutical Logistics Market, by Mode of Transportation
Global Biopharmaceutical Logistics Market, by Service
Global Biopharmaceutical Logistics Market, by Geography
Rest of APAC
Rest of Europe
Rest of Latin America
Middle East & Africa
Rest of Middle East & Africa
Request for Discount this report – @ http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=23858
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453